Yahoo
NYSE American - Nasdaq Real Time Price USD

cbdMD, Inc. (YCBD)

0.4999 +0.0099 (+2.02%)
At close: September 1 at 3:59:39 PM EDT
0.4800 -0.0163 (-3.28%)
Pre-Market: 8:58:42 AM EDT
Chart Range Bar
Loading chart for YCBD
  • Previous Close 0.4900
  • Open 0.4951
  • Bid --
  • Ask 0.5700 x 20000
  • Day's Range 0.4919 - 0.5100
  • 52 Week Range 0.4650 - 2.5600
  • Volume 113,479
  • Avg. Volume 186,406
  • Market Cap (intraday) 5.601M
  • Beta (5Y Monthly) 2.17
  • PE Ratio (TTM) 2.17
  • EPS (TTM) 0.2300
  • Earnings Date (est.) --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

cbdMD, Inc. produces and distributes various cannabidiol (CBD) products in the United States and internationally. The company owns and operates various consumer hemp-based CBD brands. Its cbdMD brand products include oils, gummies, capsules, soft-gels, topicals, functional formulations, and hemp-derived compliant Delta-9 THC products. It also provides products for dogs and cats, including tinctures, chews, and topicals under the Paw CBD brand name; non-cannabinoid functional ingredients, such as functional mushrooms under the ATRx brand; and hemp-derived solutions under the Herbal Oasis brand. It serves retailers, and health and pet channels through the direct-to-consumer channel, e-commerce platforms, online marketplaces, and wholesale distribution. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. is based in Charlotte, North Carolina.

www.cbdmd.com

42

Full Time Employees

September 30

Fiscal Year Ends

Healthcare

Sector

Performance Overview

Trailing total returns as of 9/1/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

YCBD
62.97%
S&P 500 (^GSPC)
11.48%

1-Year Return

YCBD
32.35%
S&P 500 (^GSPC)
18.13%

3-Year Return

YCBD
94.47%
S&P 500 (^GSPC)
69.00%

5-Year Return

YCBD
99.94%
S&P 500 (^GSPC)
68.69%

Earnings Trends

View More

Earnings Per Share (GAAP)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 5.64M
Earnings -797.98k
Profit Margin -14.15%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

0
2M
4M
-15.0%
-10.0%

Analyst Insights

View More

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 8/17/2026
Analyst Maxim Group
Rating Action Downgrade
Rating Hold
Price Action --
Price Target --

Statistics

View More

Valuation Measures

Annual
As of 8/31/2026
  • Market Cap

    5.49M

  • Enterprise Value

    5.59M

  • Trailing P/E

    2.13

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.23

  • Price/Book (mrq)

    0.67

  • Enterprise Value/Revenue

    0.27

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -13.80%

  • Return on Assets (ttm)

    -15.75%

  • Return on Equity (ttm)

    -40.33%

  • Revenue (ttm)

    20.93M

  • Net Income Avi to Common (ttm)

    -3.08M

  • Diluted EPS (ttm)

    0.2300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.12M

  • Total Debt/Equity (mrq)

    26.94%

  • Levered Free Cash Flow (ttm)

    -1.05M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

0.4999 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: